At this AEI event, panelists will discuss the practical potential and wisdom of further changes to patent law designed to promote innovation and entrepreneurial vigor in the United States.

An amicus brief regarding Abigail Alliance v. FDA.

This study finds that contingent fees benefit plaintiffs and do not cause higher awards.

Critics of the U.S. tort system often argue that the contingency fee system provides incentives for excessive litigation. Many of the criticisms and suggested policy reforms are based, however, on anecdotal evidence, rather than on systematic study of the contingency fee system. While capping contingency fees is still one...

When any economy faces challenges, the first thing it should do is determine if it has any self-inflicted wounds, as those are the easiest to correct. The evidence is clear that the benefits of skilled immigration are high. The costs of bad immigration are also high. It is past time for the nation to stop shooting itself in the foot.

A new book from the AEI Press finds that contingent fees benefit plaintiffs and do not cause higher awards.

Online registration for this event is closed. Walk-in registrations will be accepted.

In the past three decades, a mounting wave of litigation has swept the United States, prompting Newsweek to describe America as “lawsuit hell.” Fear of litigation has reduced innovation, menaced the health-care industry, driven manufacturers out of lawsuit-prone specialties,...

While everyone says they want more innovation, words are easy. The tough, practical questions remain: How do we get more innovation and how do we harness it?